Compound offers a potential tool for fighting drug-resistant malaria parasites.

A lung cancer researcher describes her journey toward a career in science at Novartis.

Meet a Senior Medical Director at Novartis who is part of our new “Women in Science” series

Spinal muscular atrophy (SMA) is the most common genetic casue of infant and toddler death. NIBR scientists are trying to make a back up gene take up the slack.

Lutz Hegemann shares how lessons learned treating patients with leprosy influenced the way he thinks about the pharmaceutical business.

Among the many Syrians uprooted by armed conflict are thousands of people with chronic conditions – such as diabetes and heart disease - whose treatment was disrupted when they fled.

Raising a child with a rare disease can feel overwhelming and isolating, but many parents end up being extremely proud of their children’s achievements.

Bertrand Bodson explains the Novartis strategy for digital innovation in asthma care.

Hundreds of millions of people worldwide await treatments for rare diseases.

Van der Kamp explains how leading by example has encouraged others to adopt flexible working models.